CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Organovo Holdings, Inc.  (ONVO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

ONVO's Revenue Year on Year Growth by Quarter and Year

Organovo Holdings,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
ONVO Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter March - 0.81 0.55 0.27
III Quarter December - 1.15 0.33 0.16
II Quarter September - 1.38 0.30 0.05
I Quarter June 0.99 0.89 0.31 0.10
FY   0.99 4.23 1.49 0.58

Financial Statements
Organovo Holdings,'s first quarter 2018 Revenue $ 0.99 millions ONVO's Income Statement
Organovo Holdings,'s first quarter 2017 Revenue $ 0.89 millions Quarterly ONVO's Income Statement
ONVO's Growth by Division See ONVO's Growth by Segment

ONVO Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter March - 47.27 % 103.7 % 125 %
III Quarter December - 248.48 % 106.25 % 14.29 %
II Quarter September - 360 % 500 % 150 %
I Quarter June 11.24 % 187.1 % 210 % -9.09 %
FY   - 183.89 % 156.9 % -



ONVO Revenue Growth Comment
Organovo Holdings, Inc. reported Revenue increase of 11.24% year on year in the first quarter, to $ 0.99 millions, this is lower than Organovo Holdings, Inc.'s recent average Revenue surge of 114.3%.

Looking into first quarter results within Biotechnology & Drugs industry 34 other companies have achieved higher Revenue growth. While Organovo Holdings, Inc.' s Revenue growth of 11.24% ranks overall at the positon no. 1283 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #35
Healthcare Sector #180
Overall #1283
Revenue Y/Y Growth Statistics
High Average Low
502 % 114.3 % -95.1 %
(Sep 30 2015)   (Sep 30 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ONVO's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ONVO's Competitors
Revenue Growth for Organovo Holdings,'s Suppliers
Revenue Growth for ONVO's Customers

You may also want to know
ONVO's Annual Growth Rates ONVO's Profitability Ratios ONVO's Asset Turnover Ratio ONVO's Dividend Growth
ONVO's Roe ONVO's Valuation Ratios ONVO's Financial Strength Ratios ONVO's Dividend Payout Ratio
ONVO's Roa ONVO's Inventory Turnover Ratio ONVO's Growth Rates ONVO's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Luminex Corp  19.16 %$ 19.155 millions
Invuity, Inc.  18.79 %$ 18.789 millions
General Cannabis Corp  18.76 %$ 18.757 millions
Celgene Corp  18.65 %$ 18.651 millions
Envision Healthcare Corp  18.64 %$ 18.645 millions
Inspiremd, Inc.  18.52 %$ 18.519 millions
Entellus Medical Inc  18.21 %$ 18.206 millions
Inogen Inc  17.51 %$ 17.509 millions
Roka Bioscience, Inc.  17.38 %$ 17.379 millions
Impax Laboratories Inc  17.09 %$ 17.088 millions
Pra Health Sciences, Inc.  17.08 %$ 17.084 millions
Vanda Pharmaceuticals Inc.  16.73 %$ 16.728 millions
Nantkwest, Inc.  16.67 %$ 16.667 millions
Hooper Holmes Inc  16.22 %$ 16.224 millions
Wound Management Technologies, Inc.  15.50 %$ 15.499 millions
Bioanalytical Systems Inc  15.50 %$ 15.496 millions
Sucampo Pharmaceuticals, Inc.  15.29 %$ 15.293 millions
U S Physical Therapy Inc  15.28 %$ 15.284 millions
Lhc Group, Inc  15.12 %$ 15.121 millions
Spark Therapeutics, Inc.  15.10 %$ 15.102 millions
Lemaitre Vascular Inc  15.03 %$ 15.025 millions
Heska Corp  14.59 %$ 14.587 millions
Delcath Systems, Inc.  14.29 %$ 14.286 millions
Sciclone Pharmaceuticals Inc  14.18 %$ 14.180 millions
Atricure, Inc.  14.01 %$ 14.012 millions
Pharmerica Corp  13.93 %$ 13.934 millions
Vca Inc  13.72 %$ 13.718 millions
Seattle Genetics Inc  13.44 %$ 13.439 millions
Cambrex Corp  13.42 %$ 13.416 millions
Integra Lifesciences Holdings Corp  13.18 %$ 13.178 millions